Acute pain. Acute pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: patients with acute pain that treated with 0.3 mg/kg interavenous Ketamine and 2.5 mg interavenous Haloperidol. 2.5 mg Haloperidol diluted with distilled water up t
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Any adult patient (age>18) with acute pain who need analgesia
Exclusion criteria
Exclusion criteria: Pain score =5 Pregnancy and post-partum women Altered mental status Allergy to ketamine or fentanyl Body weight = 46 kg or = 115 Unstable vital signs: BP= 90 mmHg or = 180 mmHg , PR=150 or =50 bits/min , RR=10 or =30 History of recent head or eye trauma History of Siesure History of elevated ICP Chronic pain Renal or hepatic failure Substance or alcohol abuse Documented psychiatric disorders Opium addiction Recent use of narcotic analgesics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score by Verbal Numerical Rating Scale (VNRS). Timepoint: 5,10,15 and 30 minutes after administration of medications. Method of measurement: Verbal Numerical Rating Scale (VNRS).;Blood pressure. Timepoint: 5,10,15 and 30 minutes after administration of medications. Method of measurement: Sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Agitation scale calculating with Richmond Agitation-Sedation Scale. Timepoint: When agitation appears. Method of measurement: Richmond Agitation-Sedation Scale.;Need for rescue analgesic. Timepoint: 10 minutes after administration of medications. Method of measurement: Asking from patient about presence of pain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Mobin Moradi
Tehran University of Medical Sciences
Outcome results
None listed